Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease—Relationships With Renal Function and Clinical Events

Introduction Drug accumulation of rivaroxaban is a concern in patients with chronic kidney disease (CKD). Data regarding the plasma rivaroxaban levels in early CKD patients and its relationship with clinical events is lacking. Methods Early CKD patients (Stage 1–3) with atrial fibrillation who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Chun-Fung, Wong, Ka-Ping, Wong, Hoi-Man, Siu, Chung-Wah, Yap, Desmond Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157352/
https://www.ncbi.nlm.nih.gov/pubmed/35662694
http://dx.doi.org/10.3389/fphar.2022.888660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157352/
https://www.ncbi.nlm.nih.gov/pubmed/35662694
http://dx.doi.org/10.3389/fphar.2022.888660

Ejemplares similares